The9 reveals impersonation of the9bit on cryptocurrency platform
Fraudulent Activity Alert: The9 has warned the9bit community about unauthorized accounts and token listings impersonating the9bit, claiming false affiliation.
No Official Tokens: The9bit has not launched or endorsed any tokens on crypto exchanges, and any claims to the contrary are scams.
Trade with 70% Backtested Accuracy
Analyst Views on NCTY
About NCTY
About the author
The9 Limited Secures Shareholder Approval for Key Resolutions at AGM
- Successful AGM: The9 Limited held its annual general meeting in Hong Kong on December 22, 2025, where several key resolutions were duly adopted, indicating the stability and transparency of the company's governance structure.
- Company Background: Since its Nasdaq listing in 2004, The9 Limited has been committed to becoming a global diversified high-tech Internet company, engaging in online gaming operations and Bitcoin mining, showcasing its ongoing development potential in the Internet sector.
- Clear Strategic Direction: The adoption of resolutions at the AGM signifies consistency in the company's future strategic direction, potentially laying the groundwork for its expansion in global markets.
- Increased Market Confidence: The support from shareholders reflects confidence in the company's growth prospects, which may positively impact its stock price and further attract investor interest.
The9 Limited Re-elects Zhu Jun as Director at AGM for Three-Year Term
- Board Re-election: At the annual general meeting held in Hong Kong, The9 Limited adopted an ordinary resolution to re-elect Zhu Jun as a director for a three-year term until the 2028 AGM, ensuring continuity and stability in corporate governance.
- Company Background: Since its Nasdaq listing in 2004, The9 Limited has committed to becoming a global diversified high-tech internet company, focusing on online gaming operations and Bitcoin mining, showcasing its ongoing potential in the internet sector.
- Strategic Significance: Zhu Jun's reappointment will help the company maintain a consistent strategic direction in the rapidly changing internet landscape, further driving innovation and development in the high-tech field.
- Shareholder Confidence: This re-election reflects shareholders' recognition of Zhu Jun's leadership capabilities, enhancing market confidence in The9's future growth, which may positively impact the company's stock price.
The9 Limited to Hold Annual General Meeting on December 22, 2025
Annual General Meeting Announcement: The9 Limited will hold its annual general meeting of shareholders on December 22, 2025, in Hong Kong to consider proposed resolutions supported by the board of directors.
Record Date for Voting: The record date for determining shareholders entitled to vote at the AGM is set for November 14, 2025, allowing holders of ordinary shares and American Depositary Shares (ADSs) to participate.
Voting Process for ADS Holders: Beneficial owners of ADSs can attend the AGM but must vote through the depositary, The Bank of New York Mellon, to exercise their voting rights.
Access to Annual Report: The9 Limited has filed its annual report with the SEC, which includes audited financial statements for the fiscal year ended December 31, 2024, and is available on the company's website.
Nanyang Biologics, supported by The9, to become publicly traded through $1.5B SPAC merger; stock prices rise
Merger Announcement: Nanyang Biologics, supported by The9 Limited, is set to merge with SPAC RF Acquisition Corp II, aiming for a public listing on Nasdaq under the ticker symbol "NYB" with a pre-transaction equity value of $1.5 billion.
Ownership and Control: Shareholders of NYB, including The9, will maintain majority ownership and board control by rolling over 100% of their equity, with the transaction expected to close in Q1 or Q2 of 2026.
The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
Proposed Business Combination: Nanyang Biologics Pte. Ltd. (NYB) has entered into a business combination agreement with RF Acquisition Corp II (RFAI), which will lead to NYB becoming a publicly listed company on Nasdaq, with an estimated pre-transaction equity value of $1.5 billion.
AI-Driven Drug Discovery Initiatives: NYB aims to enhance drug discovery through its AI platform and a partnership with Nvidia, HP, and Equinix to create the world's largest natural compound library, focusing on developing precision medicines for cancer and other health issues.
Impersonation of 9bit on a Cryptocurrency Platform
Fraudulent Listings Alert: The9 Limited warns the public about unauthorized accounts and token listings impersonating the9bit, stating these are scams and not affiliated with the9bit in any way.
Community Safety Measures: The9bit is actively working with a crypto platform's legal team to address the impersonation and urges users to verify announcements through official channels, report suspicious activity, and avoid engaging with fraudulent listings.
The9 Limited Secures Shareholder Approval for Key Resolutions at AGM
- Successful AGM: The9 Limited held its annual general meeting in Hong Kong on December 22, 2025, where several key resolutions were duly adopted, indicating the stability and transparency of the company's governance structure.
- Company Background: Since its Nasdaq listing in 2004, The9 Limited has been committed to becoming a global diversified high-tech Internet company, engaging in online gaming operations and Bitcoin mining, showcasing its ongoing development potential in the Internet sector.
- Clear Strategic Direction: The adoption of resolutions at the AGM signifies consistency in the company's future strategic direction, potentially laying the groundwork for its expansion in global markets.
- Increased Market Confidence: The support from shareholders reflects confidence in the company's growth prospects, which may positively impact its stock price and further attract investor interest.
The9 Limited Re-elects Zhu Jun as Director at AGM for Three-Year Term
- Board Re-election: At the annual general meeting held in Hong Kong, The9 Limited adopted an ordinary resolution to re-elect Zhu Jun as a director for a three-year term until the 2028 AGM, ensuring continuity and stability in corporate governance.
- Company Background: Since its Nasdaq listing in 2004, The9 Limited has committed to becoming a global diversified high-tech internet company, focusing on online gaming operations and Bitcoin mining, showcasing its ongoing potential in the internet sector.
- Strategic Significance: Zhu Jun's reappointment will help the company maintain a consistent strategic direction in the rapidly changing internet landscape, further driving innovation and development in the high-tech field.
- Shareholder Confidence: This re-election reflects shareholders' recognition of Zhu Jun's leadership capabilities, enhancing market confidence in The9's future growth, which may positively impact the company's stock price.
The9 Limited to Hold Annual General Meeting on December 22, 2025
Annual General Meeting Announcement: The9 Limited will hold its annual general meeting of shareholders on December 22, 2025, in Hong Kong to consider proposed resolutions supported by the board of directors.
Record Date for Voting: The record date for determining shareholders entitled to vote at the AGM is set for November 14, 2025, allowing holders of ordinary shares and American Depositary Shares (ADSs) to participate.
Voting Process for ADS Holders: Beneficial owners of ADSs can attend the AGM but must vote through the depositary, The Bank of New York Mellon, to exercise their voting rights.
Access to Annual Report: The9 Limited has filed its annual report with the SEC, which includes audited financial statements for the fiscal year ended December 31, 2024, and is available on the company's website.
Nanyang Biologics, supported by The9, to become publicly traded through $1.5B SPAC merger; stock prices rise
Merger Announcement: Nanyang Biologics, supported by The9 Limited, is set to merge with SPAC RF Acquisition Corp II, aiming for a public listing on Nasdaq under the ticker symbol "NYB" with a pre-transaction equity value of $1.5 billion.
Ownership and Control: Shareholders of NYB, including The9, will maintain majority ownership and board control by rolling over 100% of their equity, with the transaction expected to close in Q1 or Q2 of 2026.
The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
Proposed Business Combination: Nanyang Biologics Pte. Ltd. (NYB) has entered into a business combination agreement with RF Acquisition Corp II (RFAI), which will lead to NYB becoming a publicly listed company on Nasdaq, with an estimated pre-transaction equity value of $1.5 billion.
AI-Driven Drug Discovery Initiatives: NYB aims to enhance drug discovery through its AI platform and a partnership with Nvidia, HP, and Equinix to create the world's largest natural compound library, focusing on developing precision medicines for cancer and other health issues.
Impersonation of 9bit on a Cryptocurrency Platform
Fraudulent Listings Alert: The9 Limited warns the public about unauthorized accounts and token listings impersonating the9bit, stating these are scams and not affiliated with the9bit in any way.
Community Safety Measures: The9bit is actively working with a crypto platform's legal team to address the impersonation and urges users to verify announcements through official channels, report suspicious activity, and avoid engaging with fraudulent listings.
